- Home
- ALGS vs BRNS Comparison
ALGS vs BRNS Comparison
Compare ALGS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- BRNS
- Stock Information
- Founded
- ALGS 2018
- BRNS 2016
- Country
- ALGS United States
- BRNS United Kingdom
- Employees
- ALGS N/A
- BRNS N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- ALGS Health Care
- BRNS Health Care
- Exchange
- ALGS Nasdaq
- BRNS Nasdaq
- Market Cap
- ALGS 36.0M
- BRNS 38.7M
- IPO Year
- ALGS 2020
- BRNS 2021
- Fundamental
- Price
- ALGS $7.20
- BRNS $1.00
- Analyst Decision
- ALGS Strong Buy
- BRNS Strong Buy
- Analyst Count
- ALGS 1
- BRNS 2
- Target Price
- ALGS $70.00
- BRNS $3.00
- AVG Volume (30 Days)
- ALGS 156.2K
- BRNS 49.6K
- Earning Date
- ALGS 08-05-2025
- BRNS 05-07-2025
- Dividend Yield
- ALGS N/A
- BRNS N/A
- EPS Growth
- ALGS N/A
- BRNS N/A
- EPS
- ALGS N/A
- BRNS N/A
- Revenue
- ALGS $3,270,000.00
- BRNS $14,969,000.00
- Revenue This Year
- ALGS N/A
- BRNS N/A
- Revenue Next Year
- ALGS N/A
- BRNS N/A
- P/E Ratio
- ALGS N/A
- BRNS N/A
- Revenue Growth
- ALGS N/A
- BRNS 4381.74
- 52 Week Low
- ALGS $3.76
- BRNS $0.64
- 52 Week High
- ALGS $46.80
- BRNS $2.14
- Technical
- Relative Strength Index (RSI)
- ALGS 62.71
- BRNS 54.11
- Support Level
- ALGS $5.47
- BRNS $0.97
- Resistance Level
- ALGS $6.12
- BRNS $1.11
- Average True Range (ATR)
- ALGS 0.59
- BRNS 0.11
- MACD
- ALGS 0.21
- BRNS 0.01
- Stochastic Oscillator
- ALGS 88.92
- BRNS 74.78
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.